Effect of Wearing a Compression Sock During Running on Muscle Soreness in Distance Runners.

NCT06225388 | Enrolling By Invitation

• 1 other identifier: 01
• Study Type: interventional
• Target: 44
• Locations: 1 country
• Sites: 1

Brief Summary

Running is the most popular physical activity worldwide. Although running provides many health benefits, it is often associated with injuries and symptoms such as delayed onset muscle soreness. There is still a paucity of interventions that can effectively minimise these symptoms in distance runners.

Conditions

Muscle Soreness; Perceived Recovery; Perceived Exertion; Affective Response; Heart Rate

Keywords

runner; garments; pain; stocking; knee; sports

Outcome Measures

Primary Outcomes (1)

• Lower limb muscle soreness.

  A visual analogue scale (VAS) will be used to measure the intensity of muscle soreness. This scale ranges from 0 (no pain) to 100 (worst possible pain).

  24 hours post-intervention.

Secondary Outcomes (5)

• Lower limb muscle soreness.

  5 minutes post-intervention, and 48 hours post-intervention.

• Perceived recovery.

  5 minutes post-intervention, 24 hours, and 48 hours post-intervention.

• Perceived exertion

  5 minutes post-intervention.

• Affective response

  5 minutes post-intervention.

• Heart rate

  Through the intervention, an average of 30 minutes.

Study Arms (2)

Compression socks

EXPERIMENTAL

For the intervention, compression socks will be used, composed of 81% polyamide, 15% elastane and 4% polypropylene (Kendall sports, Kendall, São Paulo, Brazil). The sock offers compression of 20 to 30 mmHg in a decreasing manner with greater pressure at the ankle and less pressure at the knee joint line. Based on the manufacturer's guidelines, the sock size will be determined by measuring the calf and ankle circumference.

Other: Compression socks

Placebo socks

PLACEBO COMPARATOR

The placebo sock will be represented by a commercial sock composed of 70% polyamide, 24% cotton and 5% elastodiene without the purpose of providing compression.

Other: Placebo socks

Interventions

Compression socks OTHER

A pair of socks corresponding to the intervention allocated will be given to the participant, by an investigator who will not participate in the evaluation, in a dark plastic bag to avoid any visual influence. We will adopt strategies to prevent information about the socks from influencing the participants' behaviour: (1) the compression and placebo socks will have the same colour, any visual detail and branding will be covered. Words or logos from the compression sock will be covered, so participants are unable to differentiate them. (2) After performing the running protocol, participants will remove their socks and return them to the investigator.

Compression socks

Placebo socks OTHER

The compression and placebo socks will have the same colour, any visual detail and branding will be covered. Words or logos from the compression sock will be covered, so participants are unable to differentiate them. (2) After performing the running protocol, participants will remove their socks and return them to the investigator.

Placebo socks

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Run consistently in the last six months (at least three times a week and at least 10 kilometres per week);
• Runners who did not run further than 42 kilometres in the last month.

You may not qualify if:

• Pregnancy;
• Any lower limbs fracture in the last 12 months;
• History of lower limb arthroplasty or osteotomy, previous venous thrombosis, kidney disease;
• Any running-related injury in the last six months. A running-related injury will be considered the presence of lower limb pain that caused restriction, stoppage of running (distance, speed, duration, or training) for at least seven days or three consecutive scheduled training sessions or the need for a health professional treatment

Sponsors & Collaborators

• Centro Universitário Augusto Motta: lead

Study Sites (1)

Centro Universitário Augusto Motta

Rio de Janeiro, 21041-020, Brazil

Location

MeSH Terms

Conditions

Myalgia; Pain

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Neuromuscular Diseases; Nervous System Diseases; Musculoskeletal Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Leandro AC Nogueira, PhD

  Centro Universitário Augusto Motta

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: QUADRUPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: January 2, 2024
• First Posted: January 25, 2024
• Study Start: January 20, 2024
• Primary Completion: July 1, 2025
• Study Completion: July 30, 2025
• Last Updated: August 15, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will share
• Shared Documents: SAP
• Access Criteria: The statistical analysis plan will be available upon request.

Locations

BR (1)